Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-04-07
DOI
https://doi.org/10.1038/s41467-026-71375-2
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development

Yuki Okuhiro, Hiroyoshi Nishikawa, Yuki Fujioka, Keisuke Watanabe et al.
Nature Communications
CAR-T cell therapy research
article

Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development

Yuki Okuhiro, Hiroyoshi Nishikawa, Yuki Fujioka, Keisuke Watanabe, Yue Yan, Yasuhiro Kojima, Takuma Kato, Yuka Maeda, Sachiko Ito, Takahiko Sato, Kazuhiro Kumagai, Hitoshi Kiyoi
article en

Abstract

No abstract available for this paper.
Nature Communications
Akita University (JP), National Cancer Centre Japan (JP), Immunité et Cancer (FR), National Cancer Research Institute (GB), Nagoya University (JP), Kindai University (JP)
Good health and well-being
Openalex Percentile: Top 21%
CAR-T cell therapy research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development — Yuki Okuhiro, Hiroyoshi Nishikawa, et al. · Nature Communications (2026) | TGRS Research Map | TGRS